NCL urges FDA and consumers to take action as GLP-1 shortage ends, but infodemic continues Media Contact: Lisa McDonald, Vice President of Communications, (202)-207-2829 May 22 Conclusion of Mass Compounded GLP-1s Should Bring Clarity but Confusion Reigns Washington, DC Despite the end of the GLP-1 shortage and May 22 FDA-issued deadline for companies to stop mass compounding of the products, the National Consumers League (NCL) is concerned that the epidemic of GLP-1 misinformation will continue to confuse consumers with fake products that can put their health at risk
Those who stayed on treatment lost an average of 11.7% of their body weight
Since they are so effective in blood sugar regulation, inositol could potentially lead to low blood sugar if you have a propensity towards that, so its extra important to check with your health care provider if you take blood sugar lowering medication
TB-500 is a synthetic fragment of Thymosin Beta-4
Months 3-6: Peak rate of weight loss as full therapeutic dose is maintained and appetite suppression is maximized
Patterson CW, Palines PA, Bartow MJ, et al